Research ArticleArticle
Adalimumab Reduces Pain, Fatigue, and Stiffness in Patients with Ankylosing Spondylitis: Results from the Adalimumab Trial Evaluating Long-Term Safety and Efficacy for Ankylosing Spondylitis (ATLAS)
DENNIS A. REVICKI, MICHELLE P. LUO, PAUL WORDSWORTH, ROBERT L. WONG, NAIJUN CHEN and JOHN C. DAVIS Jr
The Journal of Rheumatology July 2008, 35 (7) 1346-1353;
DENNIS A. REVICKI
MICHELLE P. LUO
PAUL WORDSWORTH
ROBERT L. WONG
NAIJUN CHEN
In this issue
Adalimumab Reduces Pain, Fatigue, and Stiffness in Patients with Ankylosing Spondylitis: Results from the Adalimumab Trial Evaluating Long-Term Safety and Efficacy for Ankylosing Spondylitis (ATLAS)
DENNIS A. REVICKI, MICHELLE P. LUO, PAUL WORDSWORTH, ROBERT L. WONG, NAIJUN CHEN, JOHN C. DAVIS
The Journal of Rheumatology Jul 2008, 35 (7) 1346-1353;
Adalimumab Reduces Pain, Fatigue, and Stiffness in Patients with Ankylosing Spondylitis: Results from the Adalimumab Trial Evaluating Long-Term Safety and Efficacy for Ankylosing Spondylitis (ATLAS)
DENNIS A. REVICKI, MICHELLE P. LUO, PAUL WORDSWORTH, ROBERT L. WONG, NAIJUN CHEN, JOHN C. DAVIS
The Journal of Rheumatology Jul 2008, 35 (7) 1346-1353;